Drug intelligence / Profile preview

Otitex

Development stage: Unknown
Lead developer: Südmedica
Modality: Small Molecules
Administration: Otic

Overview

Otitex (also known as Otitex Lösung) is a topical otic solution developed and marketed by the German pharmaceutical company Südmedica GmbH. It is a combination product containing ethanol, glycerol, and docusate sodium, formulated in a buffered aqueous base. Classified as a medical device, Otitex is used for the softening and removal of hardened earwax (cerumen). It is indicated for general ear hygiene, as a preparatory treatment before medical ear examinations or the application of local medications, and for the maintenance of ear canal cleanliness in hearing aid users. The product is available over-the-counter (OTC) in Germany and works through physical and chemical mechanisms rather than by binding to specific biological targets.

Brand names: OtitexOtitex Lösung
Other names: Otitex ear solution

Beyond the preview

Go deeper on Otitex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Otitex.

Explore the full profile